Allworth Financial’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.5K Sell
2,354
-70
-3% -$411 ﹤0.01% 3964
2026
Q2
$11.7K Buy
2,424
+1,440
+146% +$8.69K ﹤0.01% 3608
2026
Q1
$6.06K Buy
984
+810
+466% +$6.73K ﹤0.01% 3845
2025
Q4
$1.81K Sell
174
-309
-64% -$3.1K ﹤0.01% 4157
2025
Q3
$4.34K Buy
483
+461
+2,095% +$4.05K ﹤0.01% 3631
2025
Q2
$286 Buy
22
+12
+120% +$180 ﹤0.01% 4258
2025
Q1
$148 Buy
+10
New +$297 ﹤0.01% 3913
2024
Q4
– Sell
-31
Closed -$1.53K – 4030
2024
Q3
$1.53K Sell
31
-18
-37% -$922 ﹤0.01% 3070
2024
Q2
$2.29K Buy
+49
New +$2.8K ﹤0.01% 2862

Other funds holding RXST

Allworth Financial's RXST Position: Q3 2026 in Review

Allworth Financial reduced its RxSight (RXST) stake by 2.9% in Q3 2026, selling an estimated $411 and leaving 2,354 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3964.

Allworth Financial first reported a position in RXST in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.7K in Q2 2026. 156 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • Allworth Financial held 2,354 shares of RxSight worth $11.5K as of Q3 2026.
  • Allworth Financial sold 70 RxSight shares in Q3 2026, an estimated $411.
  • RxSight made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #3964 holding.
  • Allworth Financial first reported a position in RxSight in Q2 2024 and has held it in 9 quarters since.
  • Allworth Financial's RxSight position peaked at $11.7K in Q2 2026.
  • 156 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.